Health
Combination of anti-HER2 breast cancer therapy and checkpoint inhibitor provides no benefit – News-Medical.Net
Adding an immune checkpoint inhibitor to anti-HER2 treatment in breast cancer does not improve pathological complete response…
Adding an immune checkpoint inhibitor to anti-HER2 treatment in breast cancer does not improve pathological complete response (pCR), according to the primary analysis of the IMpassion050 trial presented today during the ESMO Virtual Plenary.
The phase III…
Continue Reading
-
Noosa News17 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News18 hours agoMotorcyclist dies in crash with truck
-
Noosa News19 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
General24 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging